Development of an Amorphous Solid Dispersion Formulation for Mitigating Mechanical Instability of Crystalline Form and Improving Bioavailability for Early Phase Clinical Studies

In this work, an amorphous solid dispersion (ASD) formulation was systematically developed to simultaneously enhance bioavailability and mitigate the mechanical instability risk of the selected crystalline form of a development drug candidate, GDC-0334. The amorphous solubility advantage calculation...

Full description

Saved in:
Bibliographic Details
Published inMolecular pharmaceutics Vol. 20; no. 5; pp. 2452 - 2464
Main Authors Chiang, Cheng W., Lubach, Joseph W., Chen, Tao, Chin, Steven, Ly, Justin, Zhang, Wei, Hou, Hao Helen, Nagapudi, Karthik
Format Journal Article
LanguageEnglish
Published United States American Chemical Society 01.05.2023
Subjects
Online AccessGet full text

Cover

Loading…